CA2131284A1 - Mode de production d'avermectines et cultures necessaires a cette fin - Google Patents

Mode de production d'avermectines et cultures necessaires a cette fin

Info

Publication number
CA2131284A1
CA2131284A1 CA 2131284 CA2131284A CA2131284A1 CA 2131284 A1 CA2131284 A1 CA 2131284A1 CA 2131284 CA2131284 CA 2131284 CA 2131284 A CA2131284 A CA 2131284A CA 2131284 A1 CA2131284 A1 CA 2131284A1
Authority
CA
Canada
Prior art keywords
avermectins
branched
chain
production
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2131284
Other languages
English (en)
Other versions
CA2131284C (fr
Inventor
Edmund W. Hafner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2131284A1 publication Critical patent/CA2131284A1/fr
Application granted granted Critical
Publication of CA2131284C publication Critical patent/CA2131284C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • C12N15/03—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002131284A 1992-03-25 1992-11-30 Mode de production d'avermectines et cultures necessaires a cette fin Expired - Fee Related CA2131284C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/857,540 US6103504A (en) 1992-03-25 1992-03-25 Process for production of avermectins and cultures therefor
US07/857,540 1992-03-25

Publications (2)

Publication Number Publication Date
CA2131284A1 true CA2131284A1 (fr) 1993-09-30
CA2131284C CA2131284C (fr) 1998-01-06

Family

ID=25326228

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002131284A Expired - Fee Related CA2131284C (fr) 1992-03-25 1992-11-30 Mode de production d'avermectines et cultures necessaires a cette fin

Country Status (10)

Country Link
US (1) US6103504A (fr)
EP (1) EP0640142B1 (fr)
JP (1) JP2858951B2 (fr)
AT (1) ATE166394T1 (fr)
BR (1) BR9207110A (fr)
CA (1) CA2131284C (fr)
DE (1) DE69225610T2 (fr)
DK (1) DK0640142T3 (fr)
ES (1) ES2115749T3 (fr)
WO (1) WO1993019194A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056939A1 (fr) * 1997-06-09 1998-12-17 Vladimir Alexandrovich Mosin Souche de streptomyces avermitilis, procede de separation de complexes d'avermectine et preparations destinees a la protection d'animaux et de vegetaux
CN102676618B (zh) * 2012-06-07 2013-11-27 浙江升华拜克生物股份有限公司 一种发酵生产阿维菌素的方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4134973A (en) * 1977-04-11 1979-01-16 Merck & Co., Inc. Carbohydrate derivatives of milbemycin and processes therefor
PH15982A (en) * 1977-10-03 1983-05-18 Merck & Co Inc Selective hydrogenation producta of c-076 compounds and derivatives thereof
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
IL56149A (en) * 1977-12-19 1989-09-28 Merck & Co Inc 13-halo and 13-deoxy derivatives of c-076 compounds,their preparation and method for the treatment of parasitic infections in animals therewith
US4203976A (en) * 1978-08-02 1980-05-20 Merck & Co., Inc. Sugar derivatives of C-076 compounds
US4200581A (en) * 1978-08-04 1980-04-29 Merck & Co., Inc. Alkyl derivatives of C-076 compounds
US4429042A (en) * 1978-09-08 1984-01-31 Merck & Co., Inc. Strain of Streptomyces for producing antiparasitic compounds
US4328335A (en) * 1979-08-13 1982-05-04 Merck & Co., Inc. Process for the interconversion of C-076 compounds
US4285963A (en) * 1980-08-07 1981-08-25 Merck & Co., Inc. Novel derivatives of C-076 compounds
US4378353A (en) * 1981-02-17 1983-03-29 Merck & Co., Inc. Novel C-076 compounds
US4333925A (en) * 1981-05-11 1982-06-08 Merck & Co., Inc. Derivatives of C-076 compounds
US4423209A (en) * 1982-02-26 1983-12-27 Merck & Co., Inc. Processes for the interconversion of avermectin compounds
PL152148B1 (en) * 1984-09-14 1990-11-30 Glaxo Group Ltd Antibiotic compounds and their preparation
HUT39739A (en) * 1984-12-04 1986-10-29 Ciba Geigy Ag Process for production of derivatives of 13,3-milbemycin and medical preparatives containing thereof
GB8502925D0 (en) * 1985-02-05 1985-03-06 Ici Plc Macrocyclic lactones
IL78621A (en) * 1985-04-30 1991-06-30 American Cyanamid Co Mylbemycin analogs,their preparation and pesticidal compositions containing them
ES8800986A1 (es) * 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
IE67373B1 (en) * 1985-09-13 1996-03-20 American Cyanamid Co Macrolide antibiotics and their preparation
EP0235085A1 (fr) * 1986-02-20 1987-09-02 Ciba-Geigy Ag Dérivés de milbémycine substitués en position 13-bêta, leur préparation et utilisation comme agents ecto- et endoparasitaires pour le traitement d'animaux et de plantes
GB8606120D0 (en) * 1986-03-12 1986-04-16 Glaxo Group Ltd Process
US4831016A (en) * 1986-10-31 1989-05-16 Merck & Co., Inc. Reduced avermectin derivatives
US5234831A (en) * 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
US5238848A (en) * 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
DE3883408T2 (de) * 1987-01-23 1993-12-09 Pfizer Verfahren zur Herstellung von Avermectinen und die verwendeten Kulturen.
US5077278A (en) * 1987-01-23 1991-12-31 Pfizer Inc. Non-natural demethylavermectins compositions and method of use
IN167980B (fr) * 1987-01-23 1991-01-19 Pfizer
US5240850A (en) * 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
GB8726730D0 (en) * 1987-11-14 1987-12-16 Pfizer Ltd Antiparasitic agents
JP2888586B2 (ja) * 1990-03-05 1999-05-10 社団法人北里研究所 エバーメクチンの特定成分を選択生産するための微生物およびその選択的製造法

Also Published As

Publication number Publication date
JP2858951B2 (ja) 1999-02-17
DK0640142T3 (da) 1998-10-07
WO1993019194A1 (fr) 1993-09-30
EP0640142A1 (fr) 1995-03-01
US6103504A (en) 2000-08-15
DE69225610T2 (de) 1998-09-17
DE69225610D1 (de) 1998-06-25
BR9207110A (pt) 1995-12-12
CA2131284C (fr) 1998-01-06
ES2115749T3 (es) 1998-07-01
EP0640142B1 (fr) 1998-05-20
JPH07501454A (ja) 1995-02-16
ATE166394T1 (de) 1998-06-15

Similar Documents

Publication Publication Date Title
MY102581A (en) Process for production of avermectins and cultures therefor
ES2059498T3 (es) Procedimiento para la produccion de avermectina b y cultivos para ello.
HUP9802557A2 (hu) Eljárás nagyléptékű plazmidtisztításra
BG103133A (en) New erythromycins and method for their preparation
WO1997014712A3 (fr) Derives sulfamate de derives 1,3,5(10)-estratriene, procede de production correspondant et compositions pharmaceutiques renfermant ces composes
AU2981284A (en) Anthracycline derivatives, a microbiological process for their preparation and their use as cytostatics
CA2131284A1 (fr) Mode de production d'avermectines et cultures necessaires a cette fin
FI960401A7 (fi) Streptomyces avermitiliksestä peräisin olevaa haarautuneiden alfaketohappojen dehydrogenaasikompleksia koodaavia geenejä
EP0313297A3 (en) Process for production of avermectin aglycones and cultures therefor
AU5244590A (en) Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use
AU6820096A (en) Selective process for the deacylation of acylated compounds
FI942725A7 (fi) Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
ATE34176T1 (de) 2'-chloropentostatin, eine diese verbindung enthaltende pharmazeutische zusammensetzung und ein mikroorganismus zur herstellung dieser verbindung.
AU3605199A (en) Process for the production of purine derivatives
EP0676475A4 (fr) Procede de production de glucide.
EP1063902B8 (fr) Procede de production de produits carnes
ES2175900T3 (es) Compuestos terpenoides lactonicos y procedimiento para su produccion.
AU603416C (en) Process for production of B avermectins and cultures therefor
MD2189B2 (en) Method for stimulating the growth of fur-producing animals

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed